potent antiviral

Related by string. * Potent . POTENT : potent topical corticosteroids . potent antioxidant . potent antioxidants . potent toxin . potent anticancer . potent carcinogen / anti viral . anti virals . antivirals . Antiviral . Antivirals : antiviral drugs Tamiflu . stockpiling antiviral drugs . antiviral medications . smallpox antiviral . antiviral medication * Potent Antiviral Activity *

Related by context. All words. (Click for frequent words.) 71 favorable pharmacokinetic profile 70 anti leukemic 69 S/GSK# 69 antiviral activity 68 solithromycin 67 immunomodulating 67 oral bioavailability 67 tolerability profile 67 vitro antiviral 67 ceftazidime 66 immunomodulatory 66 retapamulin 65 sunitinib Sutent ® 65 imatinib Gleevec ® 65 Thiovir 65 antiviral potency 65 potent anticancer 65 BAL# [001] 65 immunomodulator 65 NXL# 65 anti proliferative 65 ganetespib 65 bactericidal activity 65 raltegravir 64 antitumor 64 antiviral efficacy 64 favorable pharmacokinetic 64 pharmacodynamic properties 64 potent neuroprotective 64 Omacetaxine mepesuccinate 64 potent antibacterial 64 pharmacokinetic interactions 64 bronchodilatory 64 ritonavir boosted 64 cytoprotective 64 tipifarnib 64 HCV replicon 64 highly immunogenic 63 radezolid 63 tigecycline 63 orally bioavailable 63 bevirimat 63 viral kinetics 63 imatinib resistant 63 nanomolar 63 Xanafide 63 potent anti angiogenic 63 liposomal formulation 63 bactericidal 63 ENMD # 63 PREZISTA r 63 oral prodrug 63 Seliciclib 63 APTIVUS r 63 immune modulatory 63 tolerability profiles 63 polymerase inhibitor 63 protein kinase inhibitor 63 Pegasys ® 62 chemotherapeutic drug 62 posaconazole 62 pomalidomide 62 enfuvirtide 62 mapatumumab 62 immune modulating 62 neuroprotective properties 62 Valortim ® 62 receptor inhibitor 62 PXD# 62 potent inhibitory 62 erlotinib Tarceva ® 62 NEUGENE 62 fusidic acid 62 anticancer activity 62 Tyrima 62 caspofungin 62 erythropoietic 62 PS# [001] 62 crizotinib PF # 62 protease inhibitor PI 62 PRTX 62 RGB # 62 heavily pretreated 62 Talactoferrin 62 MET amplification 62 HCV protease 62 Valortim 61 oral antiviral 61 milatuzumab 61 lenalidomide Revlimid R 61 plus prednisone prednisolone 61 nucleoside analogues 61 azoles 61 recurrent genital herpes 61 lopinavir 61 Anidulafungin 61 virologic 61 torezolid 61 anti amnesic 61 Traficet EN 61 potent antitumor 61 CBLC# 61 amprenavir 61 NEUGENE antisense 61 CYC# 61 pharmacodynamic PD 61 pharmacokinetic profiles 61 anti neoplastic 61 uric acid lowering 61 neuraminidase inhibitor 61 antitumor activity 61 echinocandins 61 nanomolar range 61 interferon IFN 61 sulindac 61 NNRTIs 61 antiinflammatory 61 talabostat 61 pharmacokinetic properties 61 XmAb# 61 evaluating tivozanib 61 echinocandin 61 immunostimulatory 61 elvucitabine 61 itraconazole 61 amrubicin 61 systemic absorption 61 YONDELIS 61 Ceftaroline 61 pan HDAC inhibitor 61 OXi# 60 velafermin 60 PRT# 60 Tarvacin 60 pro apoptotic 60 HCV genotypes 60 T#I mutant 60 indinavir 60 idarubicin 60 trabectedin 60 CXB# 60 INCB# [001] 60 pharmacodynamic 60 flavopiridol 60 macrolide antibiotic 60 Gleevec resistant 60 ritonavir boosted protease inhibitor 60 BNC# 60 potent antiproliferative 60 factor TNF 60 urate lowering 60 tolerability 60 estramustine 60 nucleoside analogs 60 nitazoxanide 60 decitabine 60 PKC# 60 pegylated interferon alfa 60 HGS ETR2 60 antithrombotic 60 immune stimulatory 60 miconazole 60 vascular disrupting 60 BAL# [002] 60 secretory phospholipase A2 sPLA2 60 Darinaparsin 60 tipranavir 60 administered subcutaneously 60 Hsp# inhibitors 60 bendamustine 60 potent cytotoxic 60 intravenously administered 60 selective modulator 60 mGluR5 NAM 60 orally administered inhibitor 60 seliciclib 60 Preclinical studies 60 xenograft models 60 NS#/#A protease 60 Interferon alpha 60 Blinatumomab 60 anticancer 60 JAK inhibitors 60 pegylated interferon alfa 2a 60 transcriptase inhibitor NNRTI 60 CDK inhibitor 60 bortezomib Velcade 60 oral rivaroxaban 60 antiproliferative 60 Aptivus ® 60 CANCIDAS 60 Bevirimat 60 nucleotide analogue 60 PREZISTA rtv 60 relapsed MM 60 nucleoside analog 60 anti angiogenic 60 Imprime PGG 60 renal toxicity 59 dose proportionality 59 antimicrobial efficacy 59 fluoroquinolone antibiotic 59 Gag polymorphisms 59 Valortim R 59 elvitegravir 59 SCH # 59 DFMO 59 #I TM# 59 XL# inhibits 59 thalidomide Thalomid 59 gemcitabine cisplatin 59 cidofovir 59 imatinib Gleevec 59 linear pharmacokinetics 59 OMP #M# 59 bronchodilation 59 tiotropium bromide 59 OHR/AVR# 59 inecalcitol 59 cetuximab Erbitux ® 59 CYT# 59 interferon alfa 2b 59 Aplidin 59 tenofovir Viread 59 human tumor xenografts 59 antiangiogenic 59 oral FTY# 59 neutralizing antibody 59 Pemetrexed 59 mTOR inhibitors 59 potent bactericidal killing 59 potent inhibitor 59 CCX# 59 microtubule targeting 59 GLYX 59 IMiDs ® 59 cytotoxic 59 meropenem 59 MEK inhibitors 59 anidulafungin 59 delafloxacin 59 cariprazine 59 novel VDA molecule 59 OncoVEX GM CSF 59 TRIOLEX 59 alvespimycin 59 GRN#L 59 insulin sensitizing 59 alpha interferon 59 DAVANAT 59 riociguat 59 Omacetaxine 59 VAPRISOL 59 APOPTONE 59 CCR5 inhibitor 59 trastuzumab Herceptin ® 59 forodesine 59 metaglidasen 59 Sym# 59 MAGE A3 ASCI 59 anticholinergic 59 selective antagonist 59 HGS ETR1 59 DAS# [001] 59 nelfinavir 59 CLORETAZINE TM VNP#M 59 fluticasone furoate 59 safety tolerability pharmacokinetic 59 preclinically 59 AMN# [001] 59 canakinumab 59 Tipranavir 59 Carfilzomib 59 polymerase inhibitors 59 Zolinza 59 intranasal formulation 59 Multimeric 59 CYT# potent vascular disrupting 59 LT NS# 59 Tarceva TM 59 protease inhibitor 59 beta lactams 59 pharmacodynamic profile 59 T#I [002] 59 subcutaneously administered 59 small molecule defensin 59 beta lactam antibiotic 59 vidofludimus 59 nanoviricides 59 neratinib 58 antitumoral 58 immunogenic 58 pharmacokinetic PK profile 58 CIMZIA ™ 58 inhaled TPI ASM8 58 pegylated liposomal doxorubicin 58 antiviral 58 IAP inhibitor 58 pharmacokinetics pharmacodynamics 58 virus HCV protease inhibitor 58 anti secretory 58 dasatinib Sprycel ® 58 alefacept 58 dexamethasone Decadron 58 favorable tolerability 58 Dasatinib 58 Ceflatonin 58 bortezomib 58 IgG antibody 58 LY# [003] 58 targeting CD# 58 preclinical efficacy 58 investigational protease inhibitor 58 seroprotection 58 pharmacokinetics PK 58 ara C 58 IgG antibodies 58 galiximab 58 pegylated 58 antifungal drugs 58 IDX# 58 neurotoxicity 58 cytotoxicity 58 gemifloxacin 58 EGFR antibodies 58 maximally tolerated dose 58 docetaxel Taxotere 58 non nucleoside HCV 58 paclitaxel Taxol 58 Maribavir 58 alkylating agent 58 inhaled iloprost 58 macrolides 58 DOXIL 58 pharmacokinetic profile 58 cMET 58 systemically administered 58 mcg dose 58 PCK# 58 low dose ritonavir 58 FFNS 58 pegylated interferon alpha 58 anti EGFR antibody 58 administered concomitantly 58 live attenuated influenza 58 selective kinase inhibitor 58 rifamycin 58 omega interferon 58 IMA# 58 adalimumab Humira 58 ISENTRESS 58 Cloretazine 58 serum antibody 58 cilengitide 58 oral antifungal 58 dose ritonavir 58 dasatinib 58 obatoclax 58 interferon alpha 58 thrombopoietin 58 antiviral antibacterial 58 erlotinib 58 CCR5 antagonist 58 Alinia 58 CCR5 tropic 58 Nitazoxanide 58 PROCHYMAL 58 rilonacept 58 DXL# 58 proteasome inhibitor 58 Epothilones 58 hemagglutination inhibition HAI 58 PI3K inhibitor 58 Ophena TM 58 DEB# 58 Cethromycin 58 IFN Beta 58 imipenem 58 CDDO Im 58 BMS # 58 AZT zidovudine Retrovir 58 HGS ETR1 mapatumumab 58 mycophenolate mofetil 58 melphalan prednisone 58 lamivudine 3TC 58 Voreloxin 58 antiangiogenic activity 58 diabetic neuropathic pain 58 Prulifloxacin 58 betamethasone dipropionate 58 #ME# 58 ATL/TV# 58 nanoviricide 58 nucleoside 58 sorafenib Nexavar 58 daptomycin 58 atovaquone 58 nucleoside reverse transcriptase inhibitor 58 INGN 58 APTIVUS 58 sorafenib Nexavar ® 58 Telmisartan 58 GHRH 58 dasatinib Sprycel 58 pegylated interferons 58 CR# vcMMAE 58 FOLFOX chemotherapy 58 enzastaurin 57 atazanavir Reyataz 57 nucleoside analogue 57 tenofovir DF 57 SAR# [004] 57 HCV protease inhibitors 57 chemopreventive 57 alfa 2a 57 Pazopanib 57 antiretroviral naive 57 INTELENCE 57 Rimantadine 57 itraconazole Sporanox 57 glucose lowering 57 telaprevir dosed 57 HSP# inhibitor 57 chemopreventive agent 57 teriflunomide 57 interferon alfa 57 IFN alpha 57 Golimumab 57 EGFR tyrosine kinase inhibitors 57 NRTI 57 radiolabeled TM# 57 Itraconazole 57 pathophysiological effects 57 subcutaneously injected 57 pramlintide metreleptin combination 57 IGFBP 3 57 zileuton 57 trastuzumab Herceptin 57 tocilizumab 57 abacavir lamivudine 57 E. faecalis 57 immunosuppressive 57 PEG SN# 57 NRTIs 57 vitro cytotoxicity 57 hemagglutination inhibition 57 AZILECT 57 HuMax EGFr 57 immunomodulatory effects 57 liposomal doxorubicin 57 antifungal 57 Virulizin ® 57 LEXIVA r 57 antitumour 57 AEG# 57 Symadex 57 TPI ASM8 57 Linaclotide 57 receptor tyrosine kinase inhibitor 57 Epivir 57 SNRI 57 imatinib 57 CTAP# Capsules 57 peginterferon alpha 2a 57 HBV vaccine 57 Cytoxan 57 demonstrated antitumor activity 57 overlapping toxicities 57 intranasal delivery 57 OncoVEX 57 pharmacokinetic 57 vitro studies 57 steroid dexamethasone 57 anakinra 57 novel anticancer 57 vivo efficacy 57 varespladib 57 generation cephalosporin antibiotic 57 panitumumab Vectibix 57 Pharmacokinetics PK 57 Immunohistochemical analysis 57 pertuzumab 57 darunavir 57 selective orally bioavailable 57 amphotericin B 57 relapsed refractory 57 potent antitumor activity 57 Tezampanel 57 AVE# 57 vinca alkaloid 57 ARIKACE 57 darunavir Prezista 57 Perifosine 57 calcineurin inhibitors 57 peripheral blood mononuclear 57 orally dosed 57 Gefitinib 57 CGEN # 57 atazanavir ritonavir 57 azacitidine 57 Pharmacokinetic studies 57 Aliskiren 57 potent triglyceride lowering 57 TMC# [001] 57 ketoconazole 57 antifibrotic 57 proguanil 57 A3 adenosine receptor 57 ImmunoVEX HSV2 57 topical antimicrobial 57 potentially hepatotoxic 57 Elvitegravir 57 pharmacologic 57 ZD# [001] 57 Aplidin R 57 Alocrest 57 replicon 57 LAB CGRP 57 REYATAZ R 57 novel immunomodulatory 57 LPV r 57 vicriviroc 57 histone deacetylase inhibitor 57 antibody responses 57 Bortezomib 57 urocortin 2 57 CIMZIA TM 57 MYDICAR ® 57 Isavuconazole 57 BRAF inhibitor 57 Vorinostat 57 transcriptase inhibitors NNRTIs 57 fluconazole 57 antineoplastic 57 rFIXFc 57 hour bronchodilation 57 GM CSF 57 isoproterenol 57 SNT MC# 57 ciclesonide 57 Talabostat 57 nephrotoxic 57 granisetron 57 emtricitabine FTC 57 Azedra 57 muscarinic 57 HCV protease inhibitor 57 antiresorptive 57 romidepsin 57 etravirine 57 RDEA# 57 ZOLINZA 57 radical scavenging 57 DACH platinum 57 azelaic acid 56 influenza VLP vaccine 56 angiotensin receptor blocker ARB 56 fulvestrant 56 HMG CoA reductase inhibitors 56 vaccine RiVax TM 56 Bavituximab 56 relapsed myeloma 56 talactoferrin 56 genotypic resistance 56 limiting toxicity 56 tumorigenic 56 hepatitis C protease inhibitor 56 lenalidomide dexamethasone 56 Antiviral 56 partial agonists 56 GAP #B# 56 TG# [003] 56 Neugene 56 RAPAFLO R 56 imatinib therapy 56 huC# DM4 56 BARACLUDE ® 56 acetylcholinesterase 56 amphotericin 56 aclidinium 56 DMARDS 56 Tarvacin TM 56 Arikace 56 Roche Pegasys 56 pharmacologically active 56 PSN# [001] 56 K ras mutations 56 sorafenib tablets 56 retaspimycin 56 Moxifloxacin 56 ceftriaxone 56 Anthim 56 monotherapy 56 nucleotide analog 56 integrase inhibitor 56 LY# [002] 56 Erlotinib 56 interferons 56 mecamylamine 56 OMNARIS HFA 56 azole 56 linezolid 56 HQK 56 YONDELIS R 56 lesinurad 56 ALN RSV# 56 CCR9 antagonist 56 nab paclitaxel 56 3TC lamivudine Epivir 56 aminoglycoside 56 Noxafil 56 bicalutamide 56 darunavir ritonavir 56 nilotinib 56 antitumour activity 56 mertansine 56 R#/MEM # 56 NNRTI resistance 56 calcitonin 56 vitro potency 56 interferon 56 chlorambucil 56 fungicidal 56 DAVANAT R exhibits 56 tinidazole 56 Kahalalide F 56 fosamprenavir 56 Onconase 56 effector function 56 beta lactam antibiotics 56 ribavirin therapy 56 CD# antibodies 56 VLP vaccine 56 vascular disrupting agent 56 IFN α 56 AKT inhibitor 56 Marqibo 56 MYCAMINE 56 VDAs 56 trastuzumab Herceptin R 56 PSN# [002] 56 voriconazole 56 Vidaza azacitidine 56 convenient dosing regimens 56 Elacytarabine 56 reverse transcriptase inhibitors 56 Engerix B 56 H#N# VLP vaccine 56 antibacterial 56 anti fibrotic 56 quinolone 56 TLR9 agonist 56 CA4P 56 topical antifungal 56 entecavir 56 Darusentan 56 uricase 56 NEUMUNE 56 Zoraxel 56 PEG Interferon lambda 56 TELCYTA 56 minocycline 56 GMX# 56 ISIS # 56 antiparasitic 56 pharmacokinetic PK 56 preclinical models 56 refractory gout 56 BAY #-# 56 fosbretabulin 56 PDE4 inhibitor 56 ganciclovir 56 Sustiva efavirenz 56 μg dose 56 MGCD# [001] 56 complete cytogenetic response 56 selective inhibition 56 anti CD3 56 pharmacokinetic characteristics 56 AEGR 56 selective inhibitor 56 Raltegravir 56 Aptivus 56 relapsed ovarian cancer 56 SERMs 56 vWF 56 protease inhibitors 56 temsirolimus 56 Rifampin 56 interferon lambda 56 biodistribution 56 Copegus ribavirin 56 cethromycin 56 baminercept 56 antifungal agent 56 μg ml 56 cisplatin gemcitabine 56 IL #E 56 HCV NS5B polymerase 56 CORT # 56 administered orally 56 interleukin IL -# 56 Preclinical studies suggest 56 ATL# [001] 56 azacytidine 56 sodium glucose cotransporter 56 tezampanel 56 nonnucleoside reverse transcriptase inhibitors 56 dosed orally 56 lipid lowering therapies 56 non nucleoside 56 efavirenz Sustiva 56 long acting beta2 56 Ribavirin 56 Darunavir 56 phase Ib 56 myopathy rhabdomyolysis 56 Radezolid 56 leukemia AML 56 vorinostat 56 imetelstat 56 iclaprim 56 INVANZ 56 griseofulvin 56 bexarotene 56 tanespimycin 56 celgosivir 56 valopicitabine 56 Atripla combines 56 forskolin 56 erlotinib Tarceva 56 fluvastatin 56 Annamycin 56 bezafibrate 56 BRAF kinase 56 TRAIL induced apoptosis 56 IMGN# 56 pleconaril 56 ritonavir boosting 56 Nanobodies 56 Kinoid 56 SCIg 56 Aurora kinase 56 cyclophosphamide Cytoxan 56 NNRTI resistant virus 56 p# inhibitor 56 cytostatic 56 HBeAg positive 56 somatostatin analog 56 multikinase inhibitor 56 dihydroergotamine 56 Peginterferon 56 adefovir dipivoxil 56 Belerofon 56 plus ribavirin 56 QTc prolongation 56 NMDA antagonist 56 preclinical studies 56 ribavirin RBV 56 amikacin 56 GRFT 56 Eltrombopag 56 ramelteon 56 HDAC inhibition 56 immunological responses 56 lopinavir ritonavir Kaletra 56 INVEGA ® 56 axitinib 56 reactogenicity 56 boosted protease inhibitor 55 plasma kallikrein 55 indibulin 55 IFN beta 55 clavulanic acid 55 pegylated alpha interferon 55 nilotinib Tasigna ® 55 lumiliximab 55 selectively inhibits 55 JVRS 55 NPH insulin 55 busulfan 55 hematological cancers 55 NNRTI 55 Panzem 55 micafungin 55 Actilon 55 alpha 2a 55 inhaled corticosteroid ICS 55 UPLYSO 55 AVN# [001] 55 recurrent glioblastoma multiforme 55 chronic HCV infection 55 octreotide acetate 55 Azixa 55 anticancer therapy 55 VELCADE melphalan 55 multi kinase inhibitor 55 partial agonist 55 investigational monoclonal antibody 55 macrolide resistant 55 Aztreonam lysine 55 genotypic 55 Hsp# Inhibitor 55 Tocilizumab 55 thymalfasin 55 Doxil ® 55 taxane resistant 55 nelfinavir Viracept 55 Lacosamide 55 TriRima 55 pharmacokinetic parameters 55 ELACYT 55 ACZ# 55 DCCR 55 Solulin 55 levetiracetam 55 neuraminidase inhibitors 55 virologically 55 abatacept Orencia 55 prucalopride 55 ANG# 55 oral dosing 55 sunitinib 55 HDAC 55 Hematologic toxicity 55 oblimersen 55 signal transduction inhibitor 55 Elotuzumab 55 INCB# [002] 55 weekly subcutaneous injections 55 GRN# 55 beta lactam 55 abatacept 55 #HT#A 55 Src inhibitors 55 MVA BN R 55 thiazolidinedione TZD 55 leflunomide 55 DPP4 55 Dabigatran etexilate 55 JAK inhibitor 55 potent CYP#A# inhibitors 55 NGX# 55 cynomolgus monkeys 55 FTY# fingolimod 55 genotoxic 55 Panzem NCD 55 antibody fragment 55 Reverset 55 histone deacetylases 55 antiemetic 55 antiepileptic 55 DU #b 55 investigational humanized monoclonal antibody 55 RoACTEMRA 55 insulin degludec 55 depsipeptide 55 pyrazinamide 55 Apoptone 55 AVP #D# 55 immunomodulation 55 MAP# 55 FUSILEV enhances 55 immunotoxin 55 Pimavanserin 55 Bcr Abl mutations 55 Teriflunomide 55 hydroxychloroquine 55 immuno modulatory 55 reslizumab 55 CELVAPAN H#N# 55 HGS# 55 antiapoptotic 55 Romidepsin 55 Telbivudine 55 standard chemotherapy regimen 55 cytarabine daunorubicin 55 Triolex 55 AV HALT 55 Hsp# inhibition 55 Eraxis 55 Rasagiline 55 anti VEGF 55 BARACLUDE R 55 immunomodulatory properties 55 lamivudine zidovudine 55 Aflibercept 55 dapsone 55 pharmacologically active isomer 55 Th1 type 55 dose limiting toxicities 55 severe hypersensitivity reactions 55 Enzastaurin 55 pharmacokinetic PK study 55 fumagillin nanoparticles 55 CCR2 55 VZV 55 endothelin receptor antagonists 55 FOSRENOL ® 55 biodefense pathogens 55 HuMax CD# 55 disease modifying antirheumatic 55 mTOR inhibitor 55 GRNVAC1 55 timolol 55 IMC A# 55 aflibercept VEGF Trap 55 alpha 2b 55 somatostatin analogue 55 Pharmacokinetic PK 55 pemetrexed Alimta 55 ROTARIX 55 mg kg dose 55 Telintra 55 miglustat 55 asthma immunotherapeutic 55 selegiline 55 AMD# [003] 55 AP# [003] 55 antitumor effect 55 Bicifadine 55 rifamycins 55 EGFR TKIs 55 iobenguane 55 indinavir Crixivan 55 Adalimumab 55 pentamidine 55 Ganetespib 55 Crofelemer 55 nucleoside reverse transcriptase inhibitors 55 nephrotoxicity 55 clomipramine 55 Gilead Viread 55 investigational oral 55 bleomycin 55 Fluconazole 55 GSK# [001] 55 torezolid phosphate 55 ZOMIG 55 PYY3 55 emtricitabine Emtriva 55 tyrosine kinase inhibitor 55 CCR9 55 Etoposide 55 olmesartan 55 Boceprevir 55 Tindamax R 55 chemotherapeutic agent 55 vascular disrupting agents 55 active comparator 55 Mitoxantrone 55 ORMD 55 ANAVEX #-# [002] 55 Insulin PH# 55 inhibitor RG# 55 C1 INH 55 highly selective inhibitor 55 intravenous bisphosphonates 55 EpCAM 55 HCV genotype 1 55 Tamibarotene 55 heparanase 55 NVA# 55 peptide antigens 55 Wellmune WGP 55 peginterferon alfa 2a 55 Debio 55 novel histone deacetylase 55 anti resorptive 55 tipranavir r 55 cleavable linker 55 Altastaph 55 alagebrium 55 CD8 responses 55 oritavancin 55 NS5B polymerase 55 chronic lymphocytic leukemia CLL 55 peripherally acting 55 virologically suppressed 55 non steroidal 55 Cyclin E 55 antiangiogenesis 55 Daptomycin 55 lamivudine 55 pharmacodynamics 55 long acting muscarinic 55 oral antidiabetic 55 systemic antifungal 55 virologic responses 55 Aclidinium 55 irinotecan doxorubicin oxaliplatin paclitaxel 55 Tolerability 55 acadesine 55 antifolates 55 nonclinical studies 55 CCR5 receptor antagonist 55 Durezol 55 IMiDs R 55 TMC# r

Back to home page